Latest News, Updates & Breaking Headlines
Biocon chief Kiran Mazumdar-Shaw Kiran Mazumdar-Shaw, founder and chairperson of Biocon, has found her successor within the family. She outlined a gradual succession plan, naming her niece Claire Mazumdar as her successor. Taking to X, she said, “Claire will transition into my role at the right time—I’m not planning to hang up my boots just…
Kiran Mazumdar-Shaw, Biocon’s founder and chairperson, has identified her niece, Claire Mazumdar, as the future leader. Kiran Mazumdar-Shaw, Biocon’s founder and chairperson, has reportedly put in place a structured succession plan for the biotechnology firm, identifying her niece, Claire Mazumdar, as the future leader.Having built Biocon over more than four decades and without a direct…
Kiran Mazumdar-Shaw is one of the most influential business leaders in India and has made significant contributions in the field of business in the area of biotechnology. She has made a mark in the field of business with her company Biocon, which has achieved global recognition in the field of biopharmaceuticals. Not only has Kiran…
Biocon staffer jumps to death from office building in Bengaluru BENGALURU: A 26-year-old employee with Biocon allegedly jumped to his death from the fifth floor of the biopharmaceutical company building on Hosur Road in Electronics City Phase II Tuesday. The reason is yet to be ascertained.The deceased is Anant Kumar, a resident of Banashankari, south…
JP Morgan has a neutral rating on Bajaj Finance with the target price at Rs 1,040. Analysts said that the recent analyst by the company underscored the company’s strategic vision to continue to deliver industry-leading growth towards achieving its goal of 3.2-3.5% of total credit market share and 3.6-4% of retail credit market share (vs…
Kiran Mazumdar-Shaw said the combined entity would position Biocon among the few global players with scale in both generics and biologics NEW DELHI: Biocon will fully integrate its biosimilars arm, Biocon Biologics into the parent, in a deal valuing the unit at $5.5 billion.The move is aimed at creating a unified biopharma powerhouse, and to…
NEW DELHI: A day after an online standoff on the city’s “poor infrastructure” with deputy chief minister D K Shivakumar, Biocon chief Kiran Mazumdar-Shaw refused to back down and, a day later, raked up Bengaluru’s unabated garbage problem on X on Thursday.Biocon chief Kiran Mazumdar-Shaw highlighted the issue calling it a “serious malaise” and criticizing…
BENGALURU: A day after Biocon chief Kiran Mazumdar-Shaw highlighted Bengaluru’s “creaking” infrastructure, Karnataka’s deputy CM D K Shivakumar Wednesday accused her of “betrayal” and of tarnishing the very state and country that helped her succeed as an entrepreneur.However, people sprang to her defence, accusing the government of displaying hostility towards those who speak up, and…
Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…
